Biotech & Pharma

Myotis Bat Genomes Reveal How They Fight Viruses, Cancer, and Cellular Damage

25 sec read0 views0 listens

Scientists have generated near-complete genome assemblies for eight species of Myotis bats, revealing unique adaptations that contribute to their longevity, cancer resistance, and viral interactions. This research identifies specific gene duplications like PKR, which may offer insights into how these bats combat cellular damage and viruses, potentially informing future studies on human aging and disease prevention.

Read the full article at Genetic Engineering News

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

You Might Like

Biotech & Pharma3 hours ago24 sec read

Ancient Peptides Resurrected from Lactoferrin's Evolutionary Past Could Point to New Antibiotics

University of Oregon biologists have resurrected ancient lactoferrin peptides up to 160 million years old, which exhibit potent antimicrobial properties against drug-resistant bacteria. This discovery could provide new avenues for developing effectiv...

Ali Nemati

Startups & VC6 hours ago27 sec read

How to Start a Business With AI: What Founders Plan

Sixty-five percent of aspiring US entrepreneurs plan to use artificial intelligence to launch their businesses in 2026, with a significant portion focusing on tasks like idea generation and market research before revenue starts coming in. This trend ...

Ali Nemati

Biotech & Pharma9 hours ago24 sec read

Centrix and University of Sussex Collaborate to Drive Data-Driven Pharma Development

Centrix Pharma Solutions and the University of Sussex have launched a Knowledge Transfer Partnership funded by Innovate UK to develop data-driven tools for pharmaceutical product development. This collaboration aims to integrate advanced analytics wi...

Ali Nemati